A clinical study on the efficacy of Xuefu Zhuyu Decoction in acute radiation esophagitis in esophageal cancer radiotherapy

Affiliated Hospital of Nanjing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1.Patients with limited stage squamous cell carcinoma of the oesophagus with clear pathological diagnosis and suitable for concurrent radiotherapy;
•2.KPS score >= 60 and expected survival > 3 months; can eat a liquid diet;
•3.Tolerate and agree to receive concurrent radiotherapy;
•4.Peripheral leukocytes >= 4.0 x 10^9/L, haemoglobin >= 90g/L and platelets >= 80 x 10^9/L before radiotherapy; no oesophageal perforation or active bleeding; no serious cardiac, pulmonary, hepatic or renal dysfunction or coagulation dysfunction;
•5.No other contraindications to radiotherapy;
•6.Willing to join this clinical study and sign the informed consent form.

•1.Those with advanced disease who are not suitable for simultaneous radiotherapy;
•2.Poor compliance; Allergy to experimental drugs;
•3.Concurrent participation in other clinical trials;
•4.Other serious illnesses, such as the combination of other tumours or serious infections;
•5.Those with mental illness or mental retardation who are unable to express symptoms accurately.

发起方

Affiliated Hospital of Nanjing University of Chinese Medicine